Sidekick Health is a technology company.
Sidekick Health develops and delivers digital health products that empower patients and digitize healthcare, focusing on multi-chronic condition management.
Sidekick Health has raised $75.0M across 2 funding rounds.
Sidekick Health has raised $75.0M in total across 2 funding rounds.
Sidekick Health has raised $75.0M in total across 2 funding rounds.
Sidekick Health's investors include Asabys Partners, Wellington Partners, Shmuel Cabilly.
Sidekick Health is a digital therapeutics company founded in 2014 that builds a gamified, AI-powered platform for managing chronic conditions, serving patients, healthcare providers, payers, and pharmaceutical companies.[1][2][3][6][8] It solves the challenge of personalized, multi-condition care at scale by combining behavioral economics, gamification, and clinical tools to boost treatment adherence, reduce hospitalizations, and improve outcomes like a 25% drop in hospitalizations and 39% fewer ER visits.[1][3][7] The platform covers 20+ therapeutic areas including oncology, cardiovascular, metabolic, inflammatory, maternity, and women's health, with products prescribed by over 13,000 physicians and partnerships with giants like Eli Lilly, Pfizer, and major US insurers covering Medicare, Medicaid, and employer plans.[1][2][5][7]
Growth momentum is strong, with clinically validated programs rated in the top 0.1% by Orcha, offices in Iceland, Berlin, Boston, and Stockholm, and collaborations across the US, Europe, and clinical trials.[1][3][5][6]
Sidekick Health was founded in 2014 by two Icelandic medical doctors who, after years treating patients with lifestyle-related chronic diseases, envisioned a tech solution to drive lasting behavioral change.[4][6][8] Frustrated by emotional drivers behind 80% of health decisions, they integrated gamification, behavioral psychology, and economics—including a helmet-wearing cartoon sidekick for nudges on exercise, smoking cessation, and medication—while adding altruistic rewards like converting user "water points" into clean water donations via charity: water.[6][8]
Early traction came from building a multidisciplinary team and launching programs that digitized care management, sparking partnerships with pharma and payers; pivotal moments include scaling to 20+ therapies and proving outcomes like reduced ER visits.[1][6]
Sidekick rides the digital therapeutics (DTx) and personalized medicine wave, addressing rising chronic disease prevalence amid aging populations and multi-morbidity, where traditional care falls short on scale and engagement.[1][2][3] Timing aligns with post-pandemic telehealth acceleration, AI maturity for adaptive paths, and payer/pharma demands for value-based care—evidenced by US insurer partnerships and EU expansions.[1][7]
Market forces like cost pressures (e.g., reducing ER/hospital use) and regulatory nods for DTx favor it, while its platform influences the ecosystem by delivering real-world data insights, boosting adherence for blockbuster drugs, and enabling "whole health" models that blend pharma with digital.[1][4][5] As gamified DTx proves ROI, Sidekick helps shift healthcare from reactive to preventive, impacting global players in life sciences and payers.[2][7]
Sidekick's trajectory points to expanded global scale, deeper AI personalization, and more clinical trial integrations, fueled by its 20+ condition breadth and outcome data.[1][5][7] Trends like AI-driven behavior change, value-based reimbursement, and oncology/men's health unmet needs will propel growth, potentially via acquisitions or IPO as DTx matures.
Its doctor-founded, "doing good by doing well" ethos—empowering patients while cutting costs—positions it to redefine chronic care, tying back to cracking personalized health at scale for a healthier future.[2][6]
Sidekick Health has raised $75.0M across 2 funding rounds. Most recently, it raised $55.0M Series B in May 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2022 | $55.0M Series B | Asabys Partners, Wellington Partners, Shmuel Cabilly | |
| Oct 1, 2020 | $20.0M Series A | Asabys Partners, Wellington Partners, Shmuel Cabilly |